Exploring iDose® TR: The Future of Glaucoma Management thumbnail

Exploring iDose® TR: The Future of Glaucoma Management

Published Dec 06, 24
1 min read


iDose® TR is a game-changing innovation in the treatment of glaucoma, providing a consistent and reliable option for managing intraocular pressure (IOP). In contrast to traditional eye drops that need to be applied every day, iDose® TR is a tiny, implantable device engineered to release a controlled release of medication directly into the eye over an extended period. This cutting-edge approach eliminates the need for frequent dosing, greatly enhancing patient adherence and overall treatment results.

At Eye Center South, we are excited to provide iDose® TR as part of our all-encompassing glaucoma care. The device is implanted during a gentle procedure, focused on your comfort and ease. Once in place, it ensures a steady flow of treatment, keeping IOP levels consistent and safeguarding your eyesight. Patients who have difficulty managing the challenges of daily eye drop regimens can benefit greatly from this state-of-the-art treatment.



Visit for more info At Eye Center South